Participants are briefed on:
- When and how covered entities can use PHI to defend themselves under HIPAA;
- State laws that may offer legitimate reasons for disclosing PHI;
- Other federal laws that may be used to broaden your use of PHI;
- Situations in which you should simply ignore the complaints; and much more
THE FACULTYMarcia L. Augsburger, JD, is a partner in the law firm, DLA Piper, where she involved in some aspects of the Shasta case and its "fall-out." Her work for clients includes litigation and counseling, contracting and developing policies, procedures, processes, and training in healthcare-related areas that require a litigator's expertise in analyzing and managing risk, such as HIPAA, EMTALA, coverage and reimbursement, health care reform measures, telemedicine, medical tourism, and fraud and abuse.
Dennis Melamed is editor and publisher of Health Information Privacy/Security Alert and the monthly HIPAA & Breach Enforcement Statistics. He is an adjunct professor at the Drexel College of Medicine where he teaches courses on issues affecting clinical trials research, including patient data stewardship, federal regulation of biomedical research and trends in medical device regulation. Dennis has served as consultant on health data stewardship issues for a number of organizations, including the National Governors Association's State Alliance for E-Health.